Tofacitinib Impurity
![Tofacitinib Impurity Structure](CAS/20210111/GIF/2282653-53-4.gif)
- CAS No.
- 2282653-53-4
- Chemical Name:
- Tofacitinib Impurity
- Synonyms
- Tofacitinib Impurity ZJT1-F;(2-Chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-dimethyl-amine;7H-Pyrrolo[2,3-d]pyrimidin-4-amine, 2-chloro-N,N-dimethyl-
- CBNumber:
- CB26226035
- Molecular Formula:
- C8H9ClN4
- Molecular Weight:
- 196.64
- MOL File:
- 2282653-53-4.mol
Tofacitinib Impurity Preparation Products And Raw materials
Raw materials
Preparation Products
Tofacitinib Impurity Suppliers
Global( 10)Suppliers
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
ANHUI WITOP BIOTECH CO., LTD | +8615255079626 | China | 23556 | 58 | Inquiry |
Shanghai Zerui Biotechnology Co., Ltd. | 021-54580889 18321124657 | China | 10614 | 58 | Inquiry |
Hubei Ruinuo Pharmaceutical Technology Co., Ltd | 13165688766 | China | 5000 | 58 | Inquiry |
QUALITY CONTROL SOLUTIONS LTD. | 13670046396 | China | 18865 | 58 | Inquiry |
Suzhou Haiben Pharmaceutical Co., Ltd | 14760821013 14760821013 | China | 5417 | 58 | Inquiry |
Shenzhen ruikai de biotechnology co., ltd. | 0755-61348847 17820674378 | China | 7844 | 58 | Inquiry |
SHENZHEN PHYSTANDARD BIO-TECH CO.,LTD | 0755-0755-0755-83725350 13380397412 | China | 9971 | 58 | Inquiry |
Nanjing SynTitan Pharmaceutical Co., Ltd. | 25-57027686 17372956142 | China | 8144 | 58 | Inquiry |
2282653-53-4(Tofacitinib Impurity)Related Search:
(3R,4R)-N,1,4-trimethyl-N-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}piperidin-3-amine
N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
Tofacitinib Impurity
Tofacitinib Impurity 36
6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine
7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]-7-[(4-Met hylphenyl)sulfonyl]-
1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, ethyl ester, (3R,4R)-
3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide
3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile
N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate
3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI)
N-(2,6-dimethylphenyl)-2-((2,6-dimethylphenyl)amino)acetamide
(3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine
1-BENZYL-N,4-DIMETHYLPIPERIDIN-3-AMINE DIHYDROCHLORIDE
chevron_left
1of4
chevron_right
Tofacitinib Impurity ZJT1-F
(2-Chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-dimethyl-amine
7H-Pyrrolo[2,3-d]pyrimidin-4-amine, 2-chloro-N,N-dimethyl-
2282653-53-4